Skip to content
Home
Researchers
Publications
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
Temporal Changes in Deceased Kidney Donor Characteristics in Australia
Post navigation
Previous:
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Next:
Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012
